Overweight
1,345
86
151
957
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
150 trials with published results (11%)
Research Maturity
957 completed trials (71% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.8%
38 terminated out of 1345 trials
96.2%
+9.6% vs benchmark
11%
142 trials in Phase 3/4
16%
150 of 957 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 957 completed trials
Clinical Trials (1345)
HealthyTogether: RCT of a Dyadic Weight Management Intervention
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
Pilot Trial of the Move Healthier Group
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain